Accera's Series A Round

Accera raised a round of funding on September 20, 2004.

Accera is a biopharmaceutical company with a drug for Alzheimer's in late stage clinical testing. Accera's pipeline consists of therapeutic drugs and medical foods for neurodegenerative diseases such …

Articles about Accera's Series A Round: